$30 million ABL Facility will support future acquisitions and be undrawn at close; can be increased to $50 million, subject to certain conditions Owned aircraft excluded from collateral package and remain unencumbered NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced that the Company has entered into a credit agreement with JPMorgan Chase Bank, N.A. for secured, asset-based revolving credit loans in aggregate principal amount of up to $30.0 million, which, subject to certain conditions, may be increased up to an aggregate of $50.0 million (the “ABL Facility”).

COLUMBUS, Ohio--(BUSINESS WIRE)--Installed Building Products, Inc. (the “Company” or “IBP”) (NYSE: IBP), an industry-leading installer of insulation and complementary building products, today announced the closing of the private offering of $500 million in aggregate principal amount of 5.625% senior unsecured notes due 2034 (the “2034 Notes”). In addition, the Company amended its existing $250 million asset-based lending revolving credit facility (“ABL Revolver”) to, among other things, increas.

Abacus Life (NASDAQ: ABL - Get Free Report) and AIA (OTCMKTS:AAGIY - Get Free Report) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, institutional ownership, earnings, profitability and dividends. Insider and Institutional Ownership 0.2% of AIA shares are

LOS ANGELES--(BUSINESS WIRE)---- $ABL--ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm.

Abacus Global Management, Inc. ( ABL ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Robert Phillips - Senior VP of Investor Relations & Corporate Affairs Jay Jackson - CEO, President & Chairman Elena Plesco - Chief Capital Officer William McCauley - Chief Financial Officer Conference Call Participants Patrick Davitt Crispin Love - Piper Sandler & Co., Research Division Mike Grondahl - Northland Capital Markets, Research Division Andrew Kligerman - TD Cowen, Research Division Timothy D'Agostino - B. Riley Securities, Inc., Research Division Presentation Operator Good day, and welcome to the Abacus Global Management Third Quarter 2025 Earnings Conference Call.

Abacus Life, Inc. (ABL) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.2 per share a year ago.

KLP Kapitalforvaltning AS bought a new position in shares of Abacus Life, Inc. (NASDAQ: ABL) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 8,000 shares of the company's stock, valued at approximately $41,000. Other hedge funds and other institutional investors have also

New agreement replaces prior ABL facility, cutting borrowing costs by up to 250 basis points New agreement replaces prior ABL facility, cutting borrowing costs by up to 250 basis points

If you purchased or acquired stock in Abacus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action.

Motion underscores that Abacus's claims lack merit as Lapetus, its key life expectancy provider, shut its doors August 31 FORT WASHINGTON, Pa. , Sept. 2, 2025 /PRNewswire/ -- Coventry First LLC ("Coventry") and its Co-Founder and Executive Chairman, Alan H.